Thank you for submitting your manuscript for consideration at The EMBO Journal. I have now received the final report from the three referees that have evaluated your study, which I enclose below. As you will see all three referees find the study describing a new role for SWI/SNF complex in regulating the deposition of Cse4 to be interesting and important. Nevertheless they also raise a number of important issues regarding the current data that need to be addressed before the manuscript can be further considered for publication. Upon reflection these concerns are central to the main conclusions of the paper and include the specificity of the observed changes in chromatin organisation at the centromeres, the ectopic deposition if Cse4 in the absence of snf2 and the specificity of SWI/SNF over other remodellers in preventing this deposition. Should be able to address these issues we would be happy to consider a revised version of the manuscript.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript. When you submit a revised version to the EMBO Journal, please make sure you upload a letter of response to the referees' comments. Please note that when preparing your letter of response to the referees' comments that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html 1. As far as I am aware, there are no published ChIP-chip analyses for yeast SWI/SNF. The authors need to make their entire data set for SWI/SNF localization available. They state in the text that SWI is localized to promoters, telomeres, etc..., but the data needs to be shown. If there is a previous study that I am forgetting, this should be referenced and the studies compared.
2. In Fig. SS2 , the authors show that the total western signal for Cse4 is similar between snf2 and WT strains. It would also be good to look at the total amount of chromatin-bound Cse4 by a quick fractionation of yeast chromatin. Based on the authors model, this level may be higher.
3. Are swi/snf mutants TBZ or benomyl sensitive? If they are affecting centromere function, I would expect some sensitivity. This should be tested or discussed.
4. Figure 4 . It looks like the snf2 pattern is grossly altered throughout this region. The authors should show data for several other regions that do not change. Also, were these data from asynchronous cultures? One potential problem would be that the mitotic delay of the snf2 mutant influences the positioning pattern, rather than any action on SWI/SNF. It would also be good to see a standard indirectly endlabeling analyses which should easily show a dramatic loss of the hypersensitive sites. Perhaps this could be done in synchronized cells (nocadozole or alpha factor).
5. Figure 5 . It looks like the Cse4 octamers are not positioned like the wt octamers. It seems possible that the altered positioning favors products that are more easily transferred to Nap1. Perhaps the authors could test whether the increased transfer activity is unique to SWI --maybe RSC action is identical between the two nucleosomes? Alternatively, maybe try an array assay with a radiolabelled, small DNA fragment as acceptor? In my opinion, the in vivo data is really the most important part of this paper, perhaps even a bit of discussion on this set of data would be sufficient.
6. I am worried about the in vivo data with the snf2 mad2 double mutants. It appears that these strains were made by successive gene deletions in haploids. swi/snf mutants are notoriously difficult to create in haploid strains, and typically they accumulate lots of secondary mutations. Since there are only ~20% changes between snf2 and snf2 mad2 mutants, I think it is essential that these deletions be performed in diploids, and several haploids be generated by tetrad dissection. This new data set will then contain data from several independent single and double mutants. This type of analysis will unambiguously demonstrate that changes in chromosome behaviour co-segregate with mad2.
Referee #2 (Remarks to the Author):
The authors of the manuscript "The SWI/SNF complex acts to constrain distribution of the centromeric histone variant Cse4." present genome-wide localization data for the SWI/SNF ATPase subunit Snf2, for nucleosomes, and for the histone variant Cse4. They find that Snf2 is enriched at centromeres and that Cse4 is redistributed to sites outside of centromeres in an snf2 deletion mutant. Further, they observe changes in nucleosome occupancy around centromeres and chromosome segregation defects in the snf2 mutant. They suggest that Snf2 is involved in the eviction of Cse4 from non-centromeric sites and attempt to show that Snf2 preferentially disassembles Cse4-containing nucleosomes in vitro.
The role of specific remodelers in governing the specific distribution of histone variants is a timely topic and mechanistically very interesting to a broad audience. Unfortunately, the data presented so far are insufficient to support a direct and specific relationship between Snf2 activity and Cse4 distribution.
Major points:
As the authors are aware of, this is not the first report on the genome-wide distribution of an SWI/SNF subunit in S. cerevisiae. Therefore it should be discussed if the enrichment of Snf2 at centromeres is not apparent in the data of, for example, Venters and Pugh, 2009 , or if these authors just did not notice.
The sum of the area under the peaks in the snf2 panels of Figure 2 seems to be much larger than that of the wt panels. Nonetheless, the authors show in Supplementary Figure 2 that the total Cse4 levels are about the same in wt and snf2 mutant. This strongly suggests that the relative ratio of free versus chromatin-incorporated Cse4 changed dramatically in the snf2 mutant. The authors should repeat their Western blot analysis after separating chromatin-bound from free Cse4. Figure 4 is derived from genome-wide nucleosome occupancy data for wt and snf2 mutant, but shows only the vicinity of centromeres. Given that the overlay profile for the snf2 mutant looks more or less like noise, it is crucial to show as positive control that the snf2 mutant nucleosome occupancy profile looks like wt at least at some loci. Specifically, loci with strong hypersensitive sites should be shown. Otherwise it is not clear if nucleosome organization is deranged all over the genome, which would undermine the Cse4-and centromere-specific effects claimed in the manuscript. Figure 5 shows potentially the strongest data when it comes to supporting a direct and specific role for SWI/SNF in Cse4 eviction. However, the data are not sufficiently developed and controlled. The addition of 160 pmol Nap1 to Cse4-containing chromatin by itself leads already to a significant increase of the free DNA fraction, something like the effect in between 20 and 40 pmol Nap1 addition in the presence of SWI/SNF and ATP (compare lanes 1 and 2 in panel A with lanes 6 and 7). The same is not true for histone H3-containing chromatin (panel B). This strongly suggests that Cse4-chromatin is intrinsically less stable, so that any remodeler may dissociate such Cse4-nucleosomes more effectively than H3-nucleosomes. In order to support a specific role for SWI/SNF, the experiment has to be repeated with another remodeler. The discrepancy between panels A and B regarding lane 2 may also mean that Nap1 shows some specificity for Cse4 over H3. If that were the case, the assay would amount to an unfair comparison. Potentially unfair as well, the Widom 601 sequence was specifically selected for high affinity of the canonical histone octamer, which need not result in similarly high affinity for a Cse4-containing octamer. Indeed, there is a heterogeneous distribution of Cse4-chromatin particles (several about equally strong chromatin bands in lane 1 of panel A), in contrast to the uniform chromatin population of the H3-chromatin (one major band in lane 1 of panel B). So the use of this particular DNA sequence may exacerbate intrinsic stability differences between Cse4-and H3-nucleosomes. Finally, the addition of increasing amounts of Nap1 seems to inhibit H3-nucleosome remodeling by SWI/SNF (compare lanes 4 to 9 in panel B). Is this expected? Does this confound the results? Why is Nap1 added at such a high molar excess over chromatin (1 pmol nucleosomes and 10-160 pmol Nap1)?
Where are the ectopic Cse4 sites in the wt? The number of 93 for the wt ( Figure 6 ) seems overly large in the light of the data shown in Supplementary Figure S1 . Where are the ectopic sites in the snf2 mutant? Is there a correlation with high or low histone turnover rates (Dion et al., 2007) ? This reviewer worries if Cse4 mainly re-distributes to promoter regions merely because of high histone turnover at these regions. As SWI/SNF is enriched at promoter, too (Venters and Pugh, 2009) , the colocalization of ectopic Cse4 sites in the snf2 mutant and Snf2 sites in the wt (first column in Figure 6 ) may be just coincidental. The same kind of analysis as in Figure 6 should be repeated for other promoter-enriched factors. It would be interesting to see how many and which hypersensitive sites fill up with nucleosomes in the snf2 mutant and how many of them are ectopic Cse4 sites. Maybe SWI/SNF is just generally involved in keeping (some) promoter regions histone depleted, so that there may be no specificity for Cse4-removal. The crucial question may be instead why Cse4 redistributes to these apparently very limited and specific sites.
The enrichment of Snf2 at Cbf1 sites shown in Supplementary Figure 4 seems to be a self-fulfilling prophecy as both Cbf1 sites and Snf2 are enriched at centromeres.
Minor, but very numerous points:
The manuscript appears put together in haste as it contains many typos, "left over" words and unclear sentences. It needs extensive editing for better readability.
The methods are not sufficiently explained in the manuscript and the representation of the data is not up to expectations. For example, which antibody or tag was used for the Cse4-ChIP-chip experiment? Probably also a myc-tag as suggested by the Western blot in Supplementary Figure 2 Points of concern Introduction Page 6: The Snf2 family member PICH has previously been implicated in centromere function by a completely different mechanism than the one described here for Snf2 (Baumann Cell. 2007 Jan 12; 128(1):101-14.) . This work should be cited and discussed It appears as if several centromeres lack Cse4 signals in snf2D. Cse4 is essential for mitosis and a cse4 conditional mutant shows a mitosis-specific arrest. I wonder how if the snf2D strain survives without any Cse4 at many centromeres? Are neo-centromeres formed?
Figure 3: Why was cen5 chosen for this assay? As judged by the data shown in Suppl Figure 1a chromosome 5 does not appear to be very representative for changes in snf2D vs wt. It has three Cse4 sites already in wt and the centromere is not marked so we do not know if Cse4 is localized at the cen5 or not in the mutant. I would like to see this assay being performed with a different centromere. It is possible that other centromeres would behave very differently in this assay. 
This a very intriguing piece of work that will be of great general interest after a bit of revision. The localization of SWI/SNF to centromeric regions, and a functional connection between SWI/SNF and Cse4 are both very novel findings. The are several issues though that need to be addressed:
We appreciate that this referee felt the work was potentially of general interest. We tested sensitivity to TBZ and benomyl. Snf2 mutants displayed sensitivity at 37oC but resistance at 20oC. We are not sure how to interpret these observations and have decided to include them in this letter of response which will be made publicly available if the manuscript is accepted. We decided not to include this in the manuscript as supplementary information as we were uncertain how to interpret the observations. 4. Figure 4 . It looks like the snf2 pattern is grossly altered throughout this region. The authors should show data for several other regions that do not change. Also, were these data from asynchronous cultures? One potential problem would be that the mitotic delay of the snf2 mutant influences the positioning pattern, rather than any action on SWI/SNF. It would also be good to see a standard indirectly endlabeling analyses which should easily show a dramatic loss of the hypersensitive sites. Perhaps this could be done in synchronized cells (nocadozole or alpha factor). The data shown in the original manuscript had not been subject to quantile normalisation to take into consideration differences in hybridisation efficiency between repeats of the same experiment. Following normalisation it is clear that a difference in the hypersensitivity remains flanking the centromers, but that this is not the case at different hypersensitive sites such as ARS elements where the digestion patterns are identical in WT and snf2 strains. This data is shown in a revised Figure 4 .
Figure It looks like the Cse4 octamers are not positioned like the wt octamers.
It is not possible to compare the position of nucleosomes with and without Cse4 from their mobility in a gel as the presence of Cse4 makes nucleosomes migrate much slower. This slower mobility is evident on 147bp DNA fragments where there is little opportunity for repositioning (data not shown). figure  4 ). This shows that the SWI/SNF mediated disruption occurs in different sequence contexts. We have also found that RSC destablises Cse4 containing nucleosomes in a way that is very similar to SWI/SNF. Published ChIP-Chip datasets for RSC show that it is also present at centromers (Venters & Pugh, 2009 ). Although there is a previous report that RSC is not required for localisation of Cse4 to centromeres (Hsu et al, 2003) , it remains possible RSC like SWI/SNF acts to remove Cse4 from ectopic sites along chromosome arms. There is however some specificity in terms of which enzymes can destablise Cse4 containing nucleosomes as we find that Chd1 does not. This is included in the new supplementary Figure 4 and discussed in the text. We had tried to make this strain originally by sporulation, but have been unable to make it this way. Instead we introduced the SNF2 deletion as the last step to reduce the potential for secondary mutations. While the difference in cell cycle distribution measured by FAX is about 20%, larger differences in the timing with which individual chromosmes are segregated were observed by microsocopy.
I am worried about the in vivo data

Referee #2 (Remarks to the Author):
The The study carried out by Venters et al was performed with a promoter specific array which did not cover centromeres.
The sum of the area under the peaks in the snf2 panels of Figure 2 seems to be much larger than that of the wt panels. Nonetheless, the authors show in Supplementary Figure 2 that We agree with the interpretation suggested by the reviewer; that the presence of Cse4 makes these nucleosomes inherently less stable. The reviewer correctly points out that Nap1 alone causes destablises 7% of the nucleosomes, but this increases to 32% in the presence of SWI/SNF. Quantitation has been added to the figure to make this clear and this point is discussed in the revised text.
In order to support a specific role for SWI/SNF, the experiment has to be repeated with another remodeler. We have included new data showing that the remodelling enzyme Chd1 is not capable of destablising Cse4 containing nucleosomes. However, we should point out that RSC functions in a similar way to SWI/SNF as mentioned in response to reviewer 1 point 5. We do not believe there is any requirement for a specific interaction between Cse4 and SWI/SNF components for the complex to influence the genomwide localisation in the way we have observed. We have included an experiment performed on a different DNA sequence (new supplementary figure 4 ). The positioning of nucleosomes assembled onto this sequence is a little more diffuse, but essentially the major conclusions remain valid. SWI/SNF acts predominantly to reposition nucleosomes that contain H3, but dissociates Cse4 containing nuclesomes in the presence of Nap1. This shows that the instability of Cse4 containing nucleosomes is not restricted to the 601 sequence.
Finally, the addition of increasing amounts of Nap1 seems to inhibit H3-nucleosome remodeling by SWI/SNF (compare lanes 4 to 9 in panel B). Is this expected? Does this confound the results?
Nap1 does appear to inhibit remodelling on the 601 sequence. This inhibition of remodelling is not observed on the weaker NucA sequence, so it is not the case that Nap1 prevents all SWI/SNF activity. It appears possible that the presence of Nap1 enables nucleosomes to slide back to their original highly favoured location. Nap1 has previously been reported to enhance nucleosome repositioning (Park et al, 2005) .
Why is Nap1 added at such a high molar excess over chromatin (1 pmol nucleosomes and 10-160 pmol Nap1)?
I think it is fair to state that the mechanism by which chaperones stimulate nucleosome removal by remodelling enzymes is not fully understood. There is a previous report that Nap1 increases the efficiency of nucleosome removal by RSC (Lorch et al, 2006) . The molar excess involve here is considerably below that previously used in these assays (Lorch et al, 2006) . Our best explanation for this that the concentration must exceed the dissociation constant for interaction of Nap1 for an intermediate in the remodelling reaction.
Where are the ectopic Cse4 sites in the wt? The number of 93 for the wt (Figure 6 ) seems overly large in the light of the data shown in Supplementary Figure S1 .
This is due to the setting of different thresholds. If the stringency for wt sites is increased the number of sites is very low. We used a low threshold to obtain a statistically significant sample. However the trend is maintained with increased stringency.
Where are the ectopic sites in the snf2 mutant? Is there a correlation with high or low histone turnover rates (Dion et al., 2007) ? This reviewer worries if Cse4 mainly re-distributes to promoter regions merely because of high histone turnover at these regions. As SWI/SNF is enriched at promoter, too (Venters and Pugh, 2009) This is a good point. In fact we had excluded centromeric centromers from the analysis for this reason. This is now made clear in the legend to what is now supplementary figure 5.
Minor, but very numerous points:
The manuscript appears put together in haste as it contains many typos, &#x201E;left over" words and unclear sentences. It needs extensive editing for better readability.
We have carefully edited the manuscript. Additional detail has been added to the methods section describing the data analysis and other points mentioned by the reviewer. The peaks of Cse4 incorporation are approximately 500bp. However, the resolution of our data is limited by the extent to which the DNA was sonicated so it would be incorrect to interpret the data any further.
Referee #3 (Remarks to the Author):
Points of concern Introduction Page 6: The Snf2 family member PICH has previously been implicated in centromere function by a completely different mechanism than the one described here for Snf2 (Baumann Cell. 2007 Jan 12; 128(1):101-14.) . This work should be cited and discussed
We should have mentioned this and have now added a sentence citing this work to the discussion on Page 13. We thought that inclusion here where we are mentioning other Snf2 related proteins with links to centromere function to be most appropriate.
Figure 1: The ChIP enrichment of Snf2 at centromere is low (about 2 fold). How does this compare to noncentromeric locations i.e. Snf2 at target gene promoters? Is the Snf2-myc allele fully functional?
Enrichment of many remodelling enzymes by ChIP has been observed to be modest, possibly reflecting the dynamic nature of their association with chromatin. 2-fold enrichment is typical of the levels of enrichment we observe for Snf2 in generic regions, and is comparable with what we have observed previously at the HO promoter (Gkikopoulos et al, 2009 ).
This Snf2-myc allele has been used previously (Cosma et al, 1999; Gkikopoulos et al, 2009 ) and shown to be functional in recruitment to and chromatin remodelling at the yeast HO promoter.
Cse4 localization It is not clear which antibody was used to detect Cse4 by ChIP (Figure 2 and methods). Was a Cse4-myc strain used? If so -is this epitope tagged allele fully functional?
More information is included on the construction of the Cse4-myc strain in the revised methods. It is impossible to be certain that there are no minor defects in the function of this allele. However, as CSE4 is essential it must be at least partially functional. In addition, it is localised predominantly at centromeres as determined by ChIP-chip (supplementary figure 1) and appears to grow normally.
Supplementary Table 1 containing strain genotypes is missing!
This has now been included.
Supplementary Figure 1: Centromere positions should be indicated.
This has been corrected.
It appears as if several centromeres lack Cse4 signals in snf2D. Cse4 is essential for mitosis and a cse4 conditional mutant shows a mitosis-specific arrest. I wonder how if the snf2D strain survives without any Cse4 at many centromeres? Are neo-centromeres formed?
There is variation in the extent to which Cse4 is depleted from centromeres in a snf2D strain. At some centromeres we do not detect Cse4 following deletion of SNF2 as the reviewer points out.
However, the snf2D strain like previously characterised cse4 alleles (Glowczewski et al, 2000) exhibits delayed progression through mitosis that is dependent on MAD2. It is possible that this delay provides the opportunity for Cse4 to transiently associate with centromeres or for neocentromeres to function. This centromere was selected as our colleagues had inserted operator binding sites flanking this centromere. It is not possible for us to generate the strains to tag other centromeres in the time available.
Figure 5: Is Nap1 required for Cse4 localization at centromeres?
We do not have evidence to indicate that Nap1 is required for Cse4 localisation to centromres in vivo. Our inclusion of Nap1 in this assay was based on the fact that it is the only factor known to promote nucleosome disassembly by SWI/SNF related complexes. If Nap1 does not perform this function in vivo it is possible that other as yet unidentified factors participate in this process. This point is discussed in the revised manuscript.
Minor points According to the legend labeling of the x-axis in Figure 4 should read 'CDE III'
Supplementary Figure 1: Labels on browser views for chromosomes I-VII are missing. Numbers indicating chromosome positions are much too small.
Thank you for submitting a revised version of your manuscript to the EMBO Journal. It has now been reviewed by two of the original referees who find that the manuscript is very much improved and recommend publication pending some minor revision. This includes further experimental analysis of the snf2 mad2 genetic interaction and also further discussion of the global effect of loss
